US Stock MarketDetailed Quotes
IPHA Innate Pharma
- 1.690
- +0.020+1.20%
Close Jan 17 16:00 ET
141.64MMarket Cap-3.92P/E (TTM)
1.740High1.650Low13.72KVolume1.730Open1.670Pre Close23.50KTurnover0.02%Turnover RatioLossP/E (Static)83.81MShares3.51152wk High4.79P/B98.21MFloat Cap1.29052wk Low--Dividend TTM58.11MShs Float11.950Historical High--Div YieldTTM5.38%Amplitude1.290Historical Low1.712Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Innate Pharma Stock Forum
Innate Pharma Announces Transformative Strategy to Accelerate Growth
Friday, 10th January at 1:00 am
Strategy anchored on early clinical development of proprietary assets with single-agent potential:
Drive innovation with first-in-class ANKET® NK-cell engager Platform
Accelerate development of differentiated Antibody-Drug Conjugates
Advance current late-stage assets through partnerships
Regulatory News:
Innate Pharma SA (PARIS: IPH, NASDAQ: IPHA) ("Innate" or the ...
Moving but not going to FOMO. Over time you will lose on these plays. You'll hit some and want more but most you will lose on.
No comment yet